| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |